北美神经刺激设备市场预测至 2030 年 - 区域分析 - 按产品(脊髓刺激器、深部脑刺激器、骶神经刺激器、迷走神经刺激器等)、应用(疼痛管理、癫痫、尿失禁和大便失禁、帕金森病)疾病等)和最终用户(医院、专科诊所等)

BMIRE00030034 | Pages: 85 | Medical Device | Apr 2024 | Type: Regional | Status: Published
2022年北美神经刺激设备市场价值为24.2264亿美元,预计到2030年将达到500080万美元;预计 2022 年至 2030 年复合年增长率为 9.5%。 神经系统疾病患病率的增加推动了北美神经刺激设备市场老年人口容易患神经系统疾病。影响老年人的常见神经系统疾病有神经病、帕金森病、阿尔茨海默病、肌张力障碍等。根据美国国立卫生研究院 (NIH) 的数据,世界人口的 8.5%(即约 6.17 亿人)年龄在 65 岁及以上。美国和加拿大等国家与老年人口增长相关的运动障碍和精神疾病患病率很高。根据帕金森基金会的数据,帕金森症状在平均 60 岁的人群中很常见。加拿大心理学协会指出,强迫症 (OCD) 影响着加拿大约 2% 的人口。世界卫生组织 (WHO) 指出,癫痫是一种引起癫痫发作的神经系统疾病,影响?全球有 5000 万人。根据美国神经病学学会的数据,中风是美国第三大死因,其次是阿尔茨海默病,是第六大死因。来自同一来源的统计数据显示,近100万美国人受到帕金森病的影响,每年至少报告6万例新病例。神经系统疾病的发病率不断上升,加上抑郁症和慢性疼痛等与生活方式相关的疾病,导致越来越多地采用先进技术产品。据世界卫生组织称,神经紊乱会导致?占全球疾病负担的 6.3%。此外,根据同一消息来源,这些疾病是世界各地死亡的主要原因之一。发达国家 13.2% 的死亡由它们造成,中低收入国家 16.8% 的死亡由它们造成。高死亡率和疾病负担使得临床迫切需要整合长期解决方案。此外,人们越来越认识到神经系统疾病的巨大负担,增加了对神经刺激器作为治疗方法的需求。因此,容易患神经系统疾病的老年人口不断增加,疾病患病率不断增加,以及人们对神经系统疾病巨大负担的认识不断提高,推动了神经刺激设备市场的增长。北美神经刺激设备市场概述北美神经刺激设备市场分为美国、加拿大和墨西哥。由于神经系统疾病的日益流行、研发支出的高额、美国食品和药物管理局(FDA)的产品批准以及技术的进步,预计北美将在全球神经刺激设备市场中占据重要份额。易患神经系统疾病的老年人口不断增加,预计将在预测期内为该地区的市场增长提供利润丰厚的机会。此外,政府为解决人们对脑部疾病日益增长的担忧而提供的越来越多的支持预计将推动该地区的市场增长。在美国,神经血管疾病的发病率正在显着上升,是全国主要死亡原因之一。帕金森病 (PD) 等神经系统疾病发病率的上升、人们对神经系统疾病的认识不断提高以及对开发经颅刺激器的投资不断增加,是推动美国整体神经刺激设备市场的主要因素。据观察,深部脑刺激(DBS)设备可以有效控制与帕金森病相关的震颤。低多巴胺读数和其他遗传因素是帕金森病的主要原因。北美神经刺激设备市场收入和预测到 2030 年(百万美元) 北美神经刺激设备市场细分 北美神经刺激设备市场根据产品、应用、最终用户和国家/地区进行细分。根据产品,北美神经刺激设备市场分为脊髓刺激器、深部脑刺激器、骶神经刺激器、迷走神经刺激器等。 2022年,脊髓刺激器细分市场占据最大的市场份额。从应用来看,北美神经刺激设备市场分为疼痛管理、癫痫、大小便失禁、帕金森病等。疼痛管理细分市场在 2022 年占据最大的市场份额。按最终用户划分,北美神经刺激设备市场分为医院、专科诊所等。 2022 年,医院细分市场占据最大的市场份额。根据国家/地区,北美神经刺激设备市场分为美国、加拿大和墨西哥。 2022 年,美国在北美神经刺激设备市场份额中占据主导地位。 美敦力公司 (Medtronic Plc)、波士顿科学公司 (Boston Scientific Corp)、雅培实验室 (Abbott Laboratories)、Nevro Corp、LivaNova Plc、Synapse Biomedical Inc、Nalu Medical Inc、ElectroCore Inc、MicroTransponder Inc 和 Mainstay Medical 等北美神经刺激设备市场的领先公司。
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Neurological Disorders

4.1.2 Rising Cases of Spinal Cord Injury

4.2 Market Restraints

4.2.1 Lack of Expert Professionals

4.3 Market Opportunities

4.3.1 Growing Advances and Approvals for Neurostimulation Devices

4.4 Future Trends

4.4.1 Rising Demand for Noninvasive Treatment

4.5 Impact Analysis

5. Neurostimulation Devices Market - North America Market Analysis

5.1 North America Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 North America Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Spinal Cord Stimulator

6.3.1 Overview

6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Deep Brain Stimulator

6.4.1 Overview

6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Sacral Nerve Stimulator

6.5.1 Overview

6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Vagus Nerve Stimulator

6.6.1 Overview

6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 North America Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Pain Management

7.3.1 Overview

7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Epilepsy

7.4.1 Overview

7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Urinary and Fecal Incontinence

7.5.1 Overview

7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Parkinson's Disease

7.6.1 Overview

7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 North America Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Specialty Clinics

8.4.1 Overview

8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 North America: Neurostimulation Devices Market

9.1.1 Overview

9.1.2 North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

9.1.2.1 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.2 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.2.1 US: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.2.2 US: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.2.3 US: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.3 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.4 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.4.1 Canada: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.4.2 Canada: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.4.3 Canada: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.5 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.6 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.6.1 Mexico: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.6.2 Mexico: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.6.3 Mexico: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

10.3 Inorganic Developments

10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corp

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Abbott Laboratories

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Nevro Corp

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 LivaNova Plc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Synapse Biomedical Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Nalu Medical, Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 ElectroCore Inc

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 MicroTransponder Inc.

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Mainstay Medical

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Neurostimulation Devices Market Segmentation

Table 2. US Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 3. US Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 4. US Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 5. Canada Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 6. Canada Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 7. Canada Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 8. Mexico Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. Mexico Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. Mexico Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 11. Organic Developments Done by Companies

Table 12. Inorganic Developments Done by Companies

Table 13. Glossary of Terms, Neurostimulation Devices Market

List of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country

Figure 2. Neurostimulation Devices Market: Key Industry Dynamics

Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints

Figure 4. North America Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030

Figure 5. North America Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. North America Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. North America Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. North America: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)

Figure 22. North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

Figure 23. US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

1. Medtronic Plc

2. Boston Scientific Corp

3. Abbott Laboratories

4. Nevro Corp

5. LivaNova Plc

6. Synapse Biomedical Inc

7. Nalu Medical, Inc

8. ElectroCore Inc

9. MicroTransponder Inc

10. Mainstay Medical

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America neurostimulation devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America neurostimulation devices market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440